Should dose from small fields be limited for dose verification procedures?: Uncertainty versus small field dose in VMAT treatments

Abstract

Over the years, radiotherapy treatments have become more complex and conformal, leading to an increased use of small field segments in volumetric modulated arc therapy (VMAT) arcs. The impact of small field dose inaccuracy on dose verification methods has not been studied yet. The aim of this work is therefore to quantify the relationship between the uncertainty of a 2D pre-treatment dose prediction model and the proportion of dose coming from small fields in VMAT arcs for a range of clinical plans. The model evaluated in this work predicts 2D portal dose images (PDIs) without a patient or phantom in the beam. The uncertainty of the model was calculated through simulation of model parameter deviations. The proportion of dose from small fields in a VMAT arc was determined by comparing a PDI with only dose from small fields with the original PDI. The uncertainty and proportion of dose from small fields were calculated for 109 VMAT arcs (41 head and neck, 33 lung, 35 prostate). The correlation was assessed with a linear regression. There is a statistically significant positive correlation between the uncertainty of the model and the proportion of dose from small fields in a VMAT arc, for each treatment site individually, as well as for all tumor sites together. The strongest relationship is found for the prostate cases. As there is a positive relationship between the uncertainty of the 2D pre-treatment dose prediction model, it may be wise to limit the dose from small fields in VMAT arcs, to avoid additional uncertainty in the dose verification process.